Basic Information
RNALocate ID: | RLID:11004348 |
RNA Symbol: | hsa-miR-1275 |
Localization: | Microvesicle |
RNA Information
RNA Name: | hsa-miR-1275 |
RNA ID: | miRBase:MIMAT0005929 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23539611 |
Tissue/Cell Line: | Seminal plasma |
Method: | Microarray |
Description: | In order to assess the reversibility of post-vasectomy miRNA sequelae, we investigated whether SMV miRNAs altered by vasectomy could be retrieved in SMVs from normospermic vasovasostomized donors. miRNA microarray profiling performed on SMVs from normal, vasectomized and vasovasostomized donors identified 313 miRNAs whose intensity was above the threshold of detection. Among these miRNAs, 293 were detected in samples from normal donors, 275 in vasectomized donors and 298 in vasovasostomized donors (Fig. 3, Supplementary data, Table SIV). Data are collected from Table S4. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002786 | Mitochondrion | HeLa cells | 27396686 |
RLID:01002787 | Mitochondrion | HeLa cells | 27563705 |
RLID:01002788 | Mitochondrion | Cell line (HeLa) | 21695135 |
RLID:01002789 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01002790 | Nucleolus | HeLa cells | 23940654 |
RLID:01002837 | Cytosol | Cell line (HeLa) | 21695135 |
RLID:01002838 | Mitochondrion | Cell line (HeLa) | 21695135 |
RLID:11004346 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
RLID:11004347 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
RLID-D:11000791 | Microvesicle | Colon cancer cell line (LIM1863)|Mesenchymal stem cells | |
RLID-D:11001721 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-1275 | Oral squamous cell carcinoma | MNDR-E-MI-08791 |
MNDR | hsa-miR-1275 | Estrogen-receptor positive breast cancer | MNDR-E-MI-08792 |
MNDR | hsa-miR-1275 | Estrogen-receptor negative breast cancer | MNDR-E-MI-08793 |
MNDR | hsa-miR-1275 | Progesterone-receptor positive breast cancer | MNDR-E-MI-08794 |
MNDR | hsa-miR-1275 | Progesterone-receptor negative breast cancer | MNDR-E-MI-08795 |
MNDR | hsa-miR-1275 | Her2-receptor positive breast cancer | MNDR-E-MI-08796 |
MNDR | hsa-miR-1275 | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-08797 |
MNDR | hsa-mir-1275 | Colorectal carcinoma | MNDR-E-MI-08798 |
MNDR | hsa-miR-1275 | B cell acute lymphoblastic leukemia | MNDR-E-MI-08799 |
MNDR | hsa-miR-1275 | Prostate cancer | MNDR-E-MI-08800 |
MNDR | hsa-miR-1275 | Alzheimer disease | MNDR-E-MI-08801 |
MNDR | hsa-miR-1275 | Intracranial aneurysm | MNDR-E-MI-08802 |
MNDR | hsa-miR-1275 | Polycystic ovary syndrome | MNDR-E-MI-08803 |
MNDR | hsa-miR-1275 | Head and neck cancer | MNDR-E-MI-08804 |
MNDR | hsa-miR-1275 | Lung cancer | MNDR-E-MI-08805 |
MNDR | hsa-miR-1275 | Parkinson disease | MNDR-E-MI-08806 |
MNDR | hsa-miR-1275 | Breast cancer | MNDR-E-MI-08807 |
MNDR | hsa-mir-1275 | Squamous carcinoma | MNDR-E-MI-08808 |
MNDR | hsa-miR-1275 | Pancreatic cancer | MNDR-E-MI-08809 |
MNDR | hsa-miR-1275 | Nephroblastoma | MNDR-E-MI-08810 |
MNDR | hsa-miR-1275 | Multiple sclerosis | MNDR-E-MI-08811 |
MNDR | hsa-miR-1275 | Multiple sclerosis relapsing-remitting | MNDR-E-MI-08812 |
MNDR | hsa-miR-1275 | Ovarian cancer | MNDR-E-MI-08813 |
MNDR | hsa-miR-1275 | Glioma | MNDR-E-MI-08814 |
MNDR | hsa-miR-1275 | Amyotrophic lateral sclerosis | MNDR-E-MI-08815 |
MNDR | hsa-miR-1275 | Liver cancer | MNDR-E-MI-08816 |
MNDR | hsa-mir-1275 | Non-small cell lung cancer | MNDR-E-MI-08817 |
MNDR | hsa-miR-1275 | Lung adenocarcinoma | MNDR-E-MI-08818 |
MNDR | hsa-miR-1275 | Thyroid carcinoma | MNDR-E-MI-08819 |
MNDR | hsa-miR-1275 | Pancreatic adenocarcinoma | MNDR-E-MI-08820 |
MNDR | hsa-miR-1275 | Intrahepatic cholangiocarcinoma | MNDR-E-MI-08821 |
MNDR | hsa-miR-1275 | Cholangiocarcinoma | MNDR-E-MI-08822 |
MNDR | hsa-miR-1275 | Adenoma | MNDR-E-MI-08823 |
MNDR | hsa-miR-1275 | Progressive supranuclear palsy | MNDR-E-MI-08824 |
MNDR | hsa-mir-1275 | Carcinoma hepatocellular | MNDR-E-MI-08825 |
MNDR | hsa-miR-1275 | Hepatocellular carcinoma | MNDR-E-MI-08826 |
MNDR | hsa-miR-1275 | Hodgkin lymphoma | MNDR-E-MI-08827 |
MNDR | hsa-miR-1275 | Acute myelocytic leukemia | MNDR-E-MI-08828 |
MNDR | hsa-mir-1275 | Colorectal cancer | MNDR-E-MI-08829 |
MNDR | hsa-mir-1275 | Nasopharyngeal carcinoma | MNDR-E-MI-08830 |
MNDR | hsa-miR-1275 | Nasopharynx carcinoma | MNDR-E-MI-08831 |
MNDR | hsa-miR-1275 | Nasopharyngeal cancer | MNDR-E-MI-08832 |
MNDR | hsa-miR-1275 | Pseudorabies | MNDR-E-MI-08833 |
MNDR | hsa-miR-1275 | Subarachnoid hemorrhage traumatic | MNDR-E-MI-08834 |
MNDR | hsa-miR-1275 | Stroke lacunar | MNDR-E-MI-08835 |
MNDR | hsa-miR-1275 | Breast cancer her3+ negative | MNDR-E-MI-08836 |
MNDR | hsa-mir-1275 | Multiple sclerosis susceptibility | MNDR-E-MI-08837 |
MNDR | hsa-mir-1275 | Stroke susceptibility | MNDR-E-MI-08838 |
MNDR | hsa-miR-1275 | Tubulovillous adenoma | MNDR-E-MI-08839 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | AK3 | Homo sapiens | RR00064570 |
TOP